The overall aim of the project is to develop and prepare for the commercialization of a remote breast cancer screening service based on FTIR (Fourier-transform infrared) spectroscopy. The partners will focus on conducting clinical trials that will build upon ISM’s initial findings that there is a specific cancer DNA phenotype that can be used as an early predictor of tumour formation in hair. This knowledge will be used to finalize the Portable FTIR Hair Spectrum Analyzer (PFHSA), a diagnostic/screening instrument based on FTIR spectroscopy that will enable performing remote infrared screening and testing. Completing this technology and building up a web platform will enable to start offering the breast cancer screening service in which ARS will provide the service of collecting samples from its patients and ISM will conduct sample analyses using its hair spectrum analyzer. The resulting data will be made available via the shared online platform.
- Conduct medical trials to collect and analyze a critical mass of hair samples.
- Finalize the Portable FTIR Hair Spectrum Analyzer that will enable performing remote infrared screening and testing.
- Develop a cloud-based SaaS solution for analyzing and storing measurement data as well as a web front-end to interact with the end customer.
- Develop a secure and scalable process to handle, analyze, and store incoming samples of human hair.
- Prepare for commercialization, e.g. specifying IPR issues to protect the joint solution, completing a viable business and execution plan for go-to-market, getting the first beta users to sign up for the service, exploring fundraising opportunities, etc.
- Carry out joint marketing activities, e.g. being visible on the web and at industry events, taking part in relevant pitching events and competitions, mapping potential investors, etc.